Skip to main content
European Psychiatry logoLink to European Psychiatry
. 2022 Sep 1;65(Suppl 1):S764–S765. doi: 10.1192/j.eurpsy.2022.1973

Vigo Insight Monitoring Scale in Schizophrenia (VIMS): validation in a sample of patients with schizophrenia

R Vazquez Noguerol Mendez 1
PMCID: PMC9568267

Abstract

Introduction

Lack of awareness of the disease is one of the most frequent symptoms (<80%) of schizophrenia, and it is accepted to have different aspects: cognitive, related to compliance, specific symptoms, and temporary. The detection of those dimensions of insight affected, allows to select and prioritize the objectives and therapeutic strategies to improve it.

Objectives

To develop a multidimensional scale for monitoring insight in schizophrenia patients

Methods

A scale with 9 insight dimensions has been developed: appreciation of symptoms, acceptance of the cause, clinical and functional repercussions, limitations and level of competence, expected evolution and prognosis, terapeutic, and other factors. risk of decompensation. Each dimension is weighted from 0-4 points, and the result is expressed numerically and graphically. The scale was administered to 60 patients with schizophrenia on three occasions. The initial one by two psychiatrists consecutively, and the third three months after stable treatment. Other clinical and sociodemographic variables were also collected.

Results

In the analysis, reliability, internal consistency, and intra- and interobserver reliability, logical, content, criterion and construct validity were assessed, obtaining satisfactory results in Cronbach’s coefficients and Pearson’s correlation (> 0.7 and > 0.8).

Conclusions

The scale has good reproducibility, validity, sensitivity and utility characteristics, which allow its use in patients with schizophrenia.

Disclosure

No significant relationships.

Keywords: insight, scale, schizophrénia


Articles from European Psychiatry are provided here courtesy of Cambridge University Press

RESOURCES